Atea Return On Assets from 2010 to 2024
| AVIR Stock | USD 3.70 0.01 0.27% |
Return On Assets | First Reported 2010-12-31 | Previous Quarter (0.23) | Current Value (0.24) | Quarterly Volatility 0.15867469 |
Check Atea PharmaceuticalsI financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Atea main balance sheet or income statement drivers, such as Net Interest Income of 30.7 M, Interest Income of 30.7 M or Depreciation And Amortization of 436.8 K, as well as many exotic indicators such as Price To Sales Ratio of 2.3, Dividend Yield of 0.0 or PTB Ratio of 0.48. Atea financial statements analysis is a perfect complement when working with Atea PharmaceuticalsI Valuation or Volatility modules.
Atea | Return On Assets |
Latest Atea PharmaceuticalsI's Return On Assets Growth Pattern
Below is the plot of the Return On Assets of Atea PharmaceuticalsInc over the last few years. It is a profitability ratio that indicates the percentage of profit a company earns in relation to its overall resources. It is calculated by dividing net income by total assets. Atea PharmaceuticalsI's Return On Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Atea PharmaceuticalsI's overall financial position and show how it may be relating to other accounts over time.
| Return On Assets | 10 Years Trend |
|
Return On Assets |
| Timeline |
Atea Return On Assets Regression Statistics
| Arithmetic Mean | (0.23) | |
| Geometric Mean | 0.21 | |
| Coefficient Of Variation | (69.03) | |
| Mean Deviation | 0.09 | |
| Median | (0.26) | |
| Standard Deviation | 0.16 | |
| Sample Variance | 0.03 | |
| Range | 0.7666 | |
| R-Value | 0.25 | |
| Mean Square Error | 0.03 | |
| R-Squared | 0.06 | |
| Significance | 0.37 | |
| Slope | 0.01 | |
| Total Sum of Squares | 0.35 |
Atea Return On Assets History
About Atea PharmaceuticalsI Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Atea PharmaceuticalsI income statement, its balance sheet, and the statement of cash flows. Atea PharmaceuticalsI investors use historical funamental indicators, such as Atea PharmaceuticalsI's Return On Assets, to determine how well the company is positioned to perform in the future. Although Atea PharmaceuticalsI investors may use each financial statement separately, they are all related. The changes in Atea PharmaceuticalsI's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Atea PharmaceuticalsI's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Atea PharmaceuticalsI Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Atea PharmaceuticalsI. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Assets | (0.23) | (0.24) |
Pair Trading with Atea PharmaceuticalsI
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Atea PharmaceuticalsI position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea PharmaceuticalsI will appreciate offsetting losses from the drop in the long position's value.Moving against Atea Stock
| 0.65 | VIRI | Virios Therapeutics Llc Financial Report 9th of May 2024 | PairCorr |
| 0.59 | VALN | Valneva SE ADR Financial Report 2nd of May 2024 | PairCorr |
| 0.54 | YS | YS Biopharma Report 22nd of April 2024 | PairCorr |
| 0.46 | SABSW | SAB Biotherapeutics | PairCorr |
| 0.44 | DOMH | Dominari Holdings | PairCorr |
The ability to find closely correlated positions to Atea PharmaceuticalsI could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Atea PharmaceuticalsI when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Atea PharmaceuticalsI - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Atea PharmaceuticalsInc to buy it.
The correlation of Atea PharmaceuticalsI is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Atea PharmaceuticalsI moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Atea PharmaceuticalsInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Atea PharmaceuticalsI can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Atea PharmaceuticalsI Correlation against competitors. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for Atea Stock analysis
When running Atea PharmaceuticalsI's price analysis, check to measure Atea PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea PharmaceuticalsI is operating at the current time. Most of Atea PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Atea PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atea PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Atea PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |
Is Atea PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atea PharmaceuticalsI. If investors know Atea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atea PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.641 | Earnings Share (1.63) | Revenue Per Share 2.31 | Quarterly Revenue Growth 2.952 | Return On Assets (0.12) |
The market value of Atea PharmaceuticalsInc is measured differently than its book value, which is the value of Atea that is recorded on the company's balance sheet. Investors also form their own opinion of Atea PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Atea PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atea PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Atea PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atea PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Atea PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atea PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.